Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors

NCT03175497 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: Telatinib Mesylate

Sponsor

Taizhou EOC Pharma Co., Ltd.

Collaborators

[object Object]